| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 8, Issue 11 1161-1169, Copyright © 1997 by American Association of Cancer Research
ARTICLES |
EI Azzam, SM de Toledo, MJ Pykett, H Nagasawa and JB Little
Laboratory of Radiobiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
The mammalian cellular response to ionizing radiation results in delays in progression through the cell cycle at several checkpoints and includes alterations in the activity of cyclin-dependent kinases. The product of the CDC2 gene is a key kinase involved in cell cycle progression. The signaling events that regulate its expression after exposure to DNA-damaging agents are not known. We show that cdc2 mRNA and protein are down-regulated after irradiation of normal human and mouse fibroblasts with doses as low as 0.5 Gy. This down-regulation is preceded by induction of p53 and p21Waf1 proteins. In human cells in which p53 was nonfunctional and in p53-/- or p21-/- mouse embryo fibroblasts, no effect of ionizing radiation on p34cdc2 expression levels was observed. These findings indicate that CDC2 down-regulation after irradiation is p53-dependent and involves the cyclin-dependent kinase inhibitor p21Waf1 as a negative factor in the control of CDC2 expression. Correspondence between the delay in initiation of DNA synthesis in irradiated cells and the down-regulation of CDC2 is described.
This article has been cited by other articles:
![]() |
B. Lu, Y. Mu, C. Cao, F. Zeng, S. Schneider, J. Tan, J. Price, J. Chen, M. Freeman, and D. E. Hallahan Survivin As a Therapeutic Target for Radiation Sensitization in Lung Cancer Cancer Res., April 15, 2004; 64(8): 2840 - 2845. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Azzam, S. M. de Toledo, and J. B. Little Expression of CONNEXIN43 Is Highly Sensitive to Ionizing Radiation and Other Environmental Stresses Cancer Res., November 1, 2003; 63(21): 7128 - 7135. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. MARKO, P. B. DIEFFENBACH, G. YAN, S. CERYAK, R. W. HOWELL, T. A. MCCAFFREY, and V. W. HU Does metabolic radiolabeling stimulate the stress response? Gene expression profiling reveals differential cellular responses to internal beta vs. external gamma radiation FASEB J, August 1, 2003; 17(11): 1470 - 1486. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki, S. Kodama, and M. Watanabe Extremely Low-Dose Ionizing Radiation Causes Activation of Mitogen-activated Protein Kinase Pathway and Enhances Proliferation of Normal Human Diploid Cells Cancer Res., July 1, 2001; 61(14): 5396 - 5401. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Flatt, L. J. Tang, C. D. Scatena, S. T. Szak, and J. A. Pietenpol p53 Regulation of G2 Checkpoint Is Retinoblastoma Protein Dependent Mol. Cell. Biol., June 15, 2000; 20(12): 4210 - 4223. [Abstract] [Full Text] |
||||
![]() |
E. I. Azzam, S. M. de Toledo, A. J. Waker, and J. B. Little High and Low Fluences of {{alpha}}-Particles Induce a G1 Checkpoint in Human Diploid Fibroblasts Cancer Res., May 1, 2000; 60(10): 2623 - 2631. [Abstract] [Full Text] |
||||
![]() |
C. Badie, J. E. Itzhaki, M. J. Sullivan, A. J. Carpenter, and A. C. G. Porter Repression of CDK1 and Other Genes with CDE and CHR Promoter Elements during DNA Damage-Induced G2/M Arrest in Human Cells Mol. Cell. Biol., April 1, 2000; 20(7): 2358 - 2366. [Abstract] [Full Text] |
||||
![]() |
R. Iyer and B. E. Lehnert Factors Underlying the Cell Growth-related Bystander Responses to {{alpha}} Particles Cancer Res., March 1, 2000; 60(5): 1290 - 1298. [Abstract] [Full Text] |
||||
![]() |
W. R. Taylor, S. E. DePrimo, A. Agarwal, M. L. Agarwal, A. H. Schönthal, K. S. Katula, and G. R. Stark Mechanisms of G2 Arrest in Response to Overexpression of p53 Mol. Biol. Cell, November 1, 1999; 10(11): 3607 - 3622. [Abstract] [Full Text] |
||||
![]() |
T. M. Passalaris, J. A. Benanti, L. Gewin, T. Kiyono, and D. A. Galloway The G2 Checkpoint Is Maintained by Redundant Pathways Mol. Cell. Biol., September 1, 1999; 19(9): 5872 - 5881. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chang, F. Chen, F. Zhang, B. C. McKay, and M. Ljungman Dose-dependent Effects of DNA-damaging Agents on p53-mediated Cell Cycle Arrest Cell Growth Differ., March 1, 1999; 10(3): 155 - 162. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |